Altshuler Shaham LTD Immunic, Inc. Transaction History
Altshuler Shaham LTD
- $2.92 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
51.2MCall Options Held
824KPut Options Held
354K-
Bvf Inc San Francisco, CA8.9MShares$11.6 Million0.33% of portfolio
-
Avidity Partners Management LP Dallas, TX7.97MShares$10.4 Million0.9% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$9.48 Million0.51% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$5.94 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.92MShares$5.1 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $39.7M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...